Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease.
Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease.
复制标题
DOI：
10.5114/ceji.2018.77395
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Pietras T
中科院分区：
文献类型：
--
作者：
Kosmalski M;Mokros Ł;Kuna P;Witusik A;Pietras T
非酒精性脂肪性肝病（NAFLD）是该器官最常见的病理之一。该疾病的发展涉及多种机制，包括胰岛素抵抗、氧化应激、内质网应激、来自肠道植物群的内毒素和遗传易感性。此外，临床数据表明，NAFLD的存在与免疫系统的过度激活有关。出于实际目的，应注意易患NAFLD的受试者在肝脏中发生炎症浸润和纤维化体征（非酒精性脂肪性肝炎- NASH）的时刻。它们的存在是肝硬化、肝衰竭和肝细胞癌以及心血管事件发生的重要危险因素。无论使用何种诊断方法，包括实验室检查和成像，肝活检仍然是识别和区分NAFLD和NASH患者的金标准。目前仍在继续寻找其他更安全、更便宜和更容易获得的诊断检测方法。已经注意到生物体免疫状态标志物的有用性，不仅用于NASH的诊断，而且用于鉴定处于疾病进展风险的NAFLD患者。尽管药物治疗有效，但尚未建立NAFLD药物治疗的建议。数据表明，主要需要非药物干预来减轻体重。然而，有证据表明某些药物和膳食补充剂的适用性，它们通过对免疫系统的影响，抑制其过度活性，从而防止NAFLD发展为NASH。
Non-alcoholic fatty liver disease (NAFLD) is one of the most common pathologies of that organ. The development of the disease involves a variety of mechanisms, including insulin resistance, oxidative stress, endoplasmic reticulum stress, endotoxins from the intestinal flora and genetic predispositions. Additionally, clinical data suggest that the presence of NAFLD is associated with excessive activation of the immune system. For practical purposes, attention should be paid to the moment when the subjects predisposed to NAFLD develop inflammatory infiltration and signs of fibrosis in the liver (non-alcoholic steatohepatitis – NASH). Their presence is an important risk factor for hepatic cirrhosis, hepatic failure, and hepatocellular carcinoma, as well as for the occurrence of cardiovascular events. Regardless of the diagnostic methods used, including laboratory tests and imaging, liver biopsy remains the gold standard to identify and differentiate patients with NAFLD and NASH. The search for other, safer, cheaper and more readily available diagnostic tests is still being continued. Attention has been drawn to the usefulness of markers of immune status of the organism, not only for the diagnosis of NASH, but also for the identification of NAFLD patients at risk of disease progression. Despite the effectiveness of medication, no recommendations have been established for pharmacotherapy of NAFLD. Data indicate the primary need for non-pharmacological interventions to reduce body weight. However, there is evidence of the applicability of certain drugs and dietary supplements, which, by their effect on the immune system, inhibit its excessive activity, thus preventing the progression of NAFLD to NASH.
登录
查看更多内容
DOI：
10.1097/meg.0000000000000486
发表时间：
2016-01-01
影响因子：
2.1
作者：
Abdel-Razik, Ahmed;Mousa, Nasser;Awad, Mahmoud
通讯作者：
Awad, Mahmoud
白藜芦醇改善非酒精性脂肪肝患者的胰岛素抵抗、葡萄糖和脂质代谢：一项随机对照试验
影响因子：
4.5
作者：
Chen, Shihui;Zhao, Xiaolan;Mi, Mantian
通讯作者：
Mi, Mantian
DOI：
10.1097/meg.0000000000000405
发表时间：
2015-10-01
影响因子：
2.1
作者：
Kara, Muammer;Dogru, Teoman;Sonmez, Alper
通讯作者：
Sonmez, Alper
影响因子：
3.8
作者：
Cepero-Donates, Yuneivy;Lacraz, Gregory;Ramanathan, Sheela
通讯作者：
Ramanathan, Sheela
影响因子：
7.1
作者：
Eslamparast, Tannaz;Poustchi, Hossein;Hekmatdoost, Azita
通讯作者：
Hekmatdoost, Azita